← All Companies
Stablecoin Development Corp
NBY · NYSE · SIC 2834: Pharmaceutical Preparations
Business Summary PART I Overview We have undergone significant changes to our business and operations as a result of a series of completed transactions summarized below and discussed in further detail under the next section titled Recent Developments below. As a result of these transactions, we have significantly reduced our legacy pharmaceutical business operations and have adopted a new strategic direction as a business, shifting to a capital allocation strategy that focuses on acquiring digital assets that pr...
Next Earnings Q2 FY2026 — expected 2026-09-20
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention NBY discussed_in_filing Cybersecurity topic_mention NBY discussed_in_filing Blockchain & Crypto topic_mention NBY discussed_in_filing Enterprise topic_mention NBY discussed_in_filing Cybersecurity topic_mention NBY discussed_in_filing Blockchain & Crypto topic_mention NBY discussed_in_filing Enterprise topic_mention NBY discussed_in_filing Cybersecurity topic_mention NBY discussed_in_filing Blockchain & Crypto topic_mention NBY discussed_in_filing Enterprise topic_mention NBY discussed_in_filing Healthcare & Bio topic_mention NBY discussed_in_filing Cybersecurity topic_mention NBY discussed_in_filing Blockchain & Crypto topic_mention NBY discussed_in_filing Enterprise topic_mention NBY discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-19 2025-12-31 0001437749-26-009090 EDGAR 77K words 2025-04-02 2024-12-31 0001437749-25-010730 EDGAR — 2024-03-26 2023-12-31 0001437749-24-009417 EDGAR — 2023-03-31 2022-12-31 0001437749-23-008843 EDGAR — 2022-03-29 2021-12-31 0001437749-22-007543 EDGAR — 2021-03-25 2020-12-31 0001437749-21-007158 EDGAR — 2020-03-26 2019-12-31 0001437749-20-006213 EDGAR — 2019-03-29 2018-12-31 0001437749-19-006017 EDGAR — 2018-03-21 2017-12-31 0001437749-18-005177 EDGAR — 2017-03-23 2016-12-31 0001437749-17-005131 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-07 2025-09-30 0001437749-25-033852 EDGAR 36K words 2025-08-14 2025-06-30 0001437749-25-026970 EDGAR — 2025-05-15 2025-03-31 0001437749-25-017064 EDGAR — 2024-11-07 2024-09-30 0001437749-24-033919 EDGAR — 2024-08-13 2024-06-30 0001437749-24-026386 EDGAR — 2024-05-09 2024-03-31 0001437749-24-015679 EDGAR — 2023-11-09 2023-09-30 0001437749-23-031256 EDGAR — 2023-08-10 2023-06-30 0001437749-23-023110 EDGAR — 2023-05-11 2023-03-31 0001437749-23-013945 EDGAR — 2022-11-14 2022-09-30 0001437749-22-027275 EDGAR — 2022-08-11 2022-06-30 0001437749-22-020119 EDGAR — 2022-05-12 2022-03-31 0001437749-22-012124 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-04-06 0001437749-26-011312 EDGAR 1K words 2026-04-01 0001437749-26-010902 EDGAR — 2026-03-23 0001437749-26-009301 EDGAR — 2026-03-12 0001437749-26-008015 EDGAR — 2026-02-20 0001437749-26-004922 EDGAR — 2026-02-12 0001437749-26-003846 EDGAR — 2026-01-30 0001437749-26-002586 EDGAR — 2026-01-28 0001437749-26-002309 EDGAR — 2026-01-20 0001437749-26-001490 EDGAR — 2026-01-16 0001437749-26-001459 EDGAR —
348 total filings indexed. 316 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001389545
Ticker NBY
Exchange NYSE
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 001fd420e75b16361ade3460de77a88b6e2c6c7c459f5cdce035e500158c6a2c
parent: ed9f0b5ea83f1db23d1256439e29afc9064f5874dd9af93be7c1cb4ba50e7f51
content hash: 6f2e30c511650598a8d56b64171d0d2d85580eeb499cb80558144694cef68276
signed: 2026-04-13T04:46:27.063Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf